Advarra Launches Study Design Solution, Powered by Braid, to Improve Operational Efficiency in Clinical Trials — Read the Press Release

Advarra Blog

FEATURED Post

Ways to Streamline Informed Consent Process in Clinical Trial Startup

Optimizing the informed consent process is critical for accelerating clinical trial startup while maintaining compliance and participant understanding. This article explores key strategies for streamlining informed consent, including leveraging electronic consent (eConsent) solutions, standardizing templates, and improving collaboration between sponsors, sites, and IRBs. By implementing these best practices, research teams can enhance efficiency, reduce delays, and improve the participant experience in clinical trials.

Read Now
Resource
Info Sheets
Reset
Blog

Virtual Symposium: Gene Therapy Research in the Age of COVID-19

Gene therapy research continues its rapid expansion in the clinical setting, especially in infectious disease,…

Read More
Blog

Generating Leadership Buy-In for a Clinical Research Business Intelligence Solution

As clinical trials increase in complexity, you gain more value from using each resource at…

Read More
Placeholder Image
Blog

Keep in Touch: Tips for Working with a Single IRB for the First Time

Recent regulations and policies have ushered in the era of mandated single IRB (sIRB) review.…

Read More
Placeholder Image
Blog

Q&A – Ask Advarra Live: The Real-World Impact of COVID-19 on Research

Experts from Advarra and Johns Hopkins University School of Medicine provided practical guidance on the…

Read More
Blog

Empowering Employees Starts with Building a Strong Culture

Now more than ever, people are seeking out employment at organizations that offer more than…

Read More
Placeholder Image
Blog

Differentiating “Public” and “Private” Internet Spaces in IRB Review

What is the difference between “public” and “private” internet spaces? This question has gained importance…

Read More
Placeholder Image
Blog

How Sites Can Prepare for COVID-19 Genetically Engineered Vaccine Studies

Currently the most prominent coronavirus vaccine candidates contain engineered genetic material. Sites wishing to participate…

Read More
Placeholder Image
Blog

Q&A Part 1 – Evaluating Payment to Participate in Research: Ethical and Regulatory Issues

In a recent webinar, Dr. Luke Gelinas, IRB Chair at Advarra, provided a framework for…

Read More
Placeholder Image
Blog

Protocol Feasibility to Promote Trial Efficiency

Scientific abstracts and articles have reported that 20-50% of studies do not accrue subjects at…

Read More
Placeholder Image
Blog

Study Activation: A Complex Process That Doesn’t Have to Be Painful

Study activation data from the Forte community shows on average, it takes about six months…

Read More
Placeholder Image
Blog

How Research Informs the COVID-19 Response

Research doesn’t just inform medical treatment; it informs public health and public policy, and it…

Read More
Placeholder Image
Blog

IRB Review of Coronavirus and Other Emerging Infectious Disease Research: Issues to Consider

In this blog we discuss unique issues that research involving emerging infectious diseases like coronavirus…

Read More

Looking for More?

To register for upcoming webinars and see where we’ll be next, go to the Events page.

Want to see the latest news and updates about Advarra? You can find them in the Newsroom.

Are You Ready To Bring People Together for Better, Faster Trial Outcomes?

Sponsors
Sites
CROs

Subscribe to our monthly email

Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.

Subscribe
Scroll to Top